Search

Your search keyword '"Fang, Haiquan"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Fang, Haiquan" Remove constraint Author: "Fang, Haiquan"
40 results on '"Fang, Haiquan"'

Search Results

6. Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties

8. Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype

9. Development of BET inhibitors as potential treatments for cancer: A search for structural diversity

12. Application of a radical methodlogy twoard the synthesis of d,1-5a-pregnanes and related steroids: a stereoselective radical cascade approach

13. Synthesis of d,l-norlabdane oxide and related odorants: an intramolecular radical approach

14. Advanced tetracycles in a stereoselective approach to d,l-spongiatriol and related metabolites: the use of radicals in the synthesis of angular electrophores

15. Synthesis of acuminolide and 17-O-acetylacuminolide from (+)-sclareolide

17. Design and synthesis of a novel series of 4-heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR

19. The relationship between the sum of reciprocal golden section numbers and the Fibonacci numbers

20. Design and synthesis of a novel series of (1′ S ,2 R ,4′ S )-3 H -4′-azaspiro[benzo[4,5]imidazo[2,1- b ]oxazole-2,2′-bicyclo[2.2.2]octanes] with high affinity for the α7 neuronal nicotinic receptor

21. BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia

23. Design and Synthesis of a New Series of 4-Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure–Activity Relationship

24. Development of 4-Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists

25. Development of 1H-Pyrazolo[3,4-b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators

26. Inhibitors of HIV-1 attachment. Part 8: The effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors

28. Calculation of water quantity and analysis of variation trend of the water intake monitoring point.

30. Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns

32. Corrigendum to “Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns” [Bioorg. Med. Chem. Lett. 19 (2009) 1977]

33. Existence of positive periodic solution of a hepatitis B virus infection model.

34. Discovery of 4-Benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions

37. Novel Tricyclic Compounds As Anticancer Agents

38. Compuestos Tricíclicos Como Agentes Anticancerígenos

39. Tricyclic Compounds As Anticancer Agents

40. Development of 1 H -Pyrazolo[3,4- b ]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators.

Catalog

Books, media, physical & digital resources